Skip to main content
Caplight Logo









MThera Pharma

MThera Pharma

Private
SeoulHealthcare & Life Scienceshttps://mtherapharma.com/

Last Round

Grant

Dec 18, 2023

Total Funding Raised

$12.06M

Company Overview

MThera Pharma is a biopharmaceutical company that develops innovative multi-target therapeutics for chronic and intractable diseases using a proprietary botanical drug platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

botanical drugdrug discoverymulti-omicschemistry, manufacturing, and controlsCMCin silico drug discoverysystems biologyneurodegenerative diseaseAI drug discoverypharma technatural product therapeuticsmulti-target drugbiotech R&Ddrug pipelinecomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MThera Pharma Comparables

Compare MThera Pharma with similar companies based on industry and business-model similarity.

MThera Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pangea Bio
83%
Standard Seed Corporation
82%
Cellarity
76%

MThera Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 18, 2023
Series BAug 25, 2022
Series AApr 8, 2021
Pre SeedJul 2, 2020
GrantJun 12, 2020
Seed
Mar 4, 2020

MThera Pharma Investors

Notable investors and investment history

MThera Pharma investors
InvestorRounds
GenaxisSeries B
ROI Investment PartnersSeries A
Woori Technology Investment Co., Ltd.Series A
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 54% MoM, reaching 5K.

  • Jun 1, 2025

    Monthly visitors grew 371% MoM, reaching 2.3K.

MThera Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MThera Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MThera Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range3
Year Founded2020
Last FundingDec 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?